UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 27, 2014

 

INTELLICELL BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

Nevada	333-49388	91-196648
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

 

460 Park Avenue, 17th Fl

New York, NY 10022

(Address of principal executive offices)

 

(646) 576-8700

(Registrant’s telephone number, including area code)

 

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 40.13e-4(c))

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective October 27, 2014, the Board of Directors of Intellicell Biosciences, Inc., a Nevada corporation (the “Company”) accepted the amicable resignation of Mr. Myron Holubiak as a director of the Company. Mr. Holubiak served on the audit committee and on the corporate governance/nominating committee at the time of his resignation. The Company intends to replace Mr. Holubiak as a board member, as well as an audit committee and corporate governance/nominating committee member, in the near future.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

			INTELLICELL BIOSCIENCES, INC.
Dated: October 28, 2014			By:	/s/ Dr. Steven Victor
				Name: Dr. Steven Victor
				Title: Chief Executive Officer

 

 

 

 

3